Nj State Employees Deferred Compensation Plan Madrigal Pharmaceuticals, Inc. Transaction History
Nj State Employees Deferred Compensation Plan
- $761 Million
- Q1 2025
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 1,500 shares of MDGL stock, worth $427,590. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,500
Previous 1,500
-0.0%
Holding current value
$427,590
Previous $462,000
7.36%
% of portfolio
0.07%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding MDGL
# of Institutions
367Shares Held
23.3MCall Options Held
979KPut Options Held
459K-
Janus Henderson Group PLC London, X02.21MShares$629 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$598 Million39.89% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$576 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$568 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$563 Million7.8% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $4.88B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...